ABO hemolytic disease of the newborn: a need for clarity and consistency in diagnosis.
Watchko JF.
J Perinatol. 2023 Feb;43(2):242-247. doi: 10.1038/s41372-022-01556-6. Epub 2022 Nov 8.
Hemolytic disease in fetuses and newborns due to antibodies against the M-antigen.
Páez M, Jiménez M, Corredor A.
Biomedica. 2021 Dec 15;41(4):643-650. doi: 10.7705/biomedica.5930.
Neonatal Blood Banking Practices.
Crowe EP, Goel R, Al-Mozain N, Josephson CD.
Clin Perinatol. 2023 Dec;50(4):821-837. doi: 10.1016/j.clp.2023.07.008. Epub 2023 Sep 20.
Fetal-maternal incompatibility in the Rh system. Rh isoimmunization associated with hereditary spherocytosis: case presentation and review of the literature.
Neamţu SD, Novac MB, Neamţu AV, Stanca ID, Boldeanu MV, Gluhovschi A, Stanca L, Dijmărescu AL, Manolea MM, Trăistaru MR, Mateescu GO, Siminel MA.
Rom J Morphol Embryol. 2022 Jan-Mar;63(1):229-235. doi: 10.47162/RJME.63.1.26.
Mechanisms of hemolysis.
Zipursky A.
Mead Johnson Symp Perinat Dev Med. 1982;(19):17-24.
Neonatal hyperbilirubinemia due to ABO incompatibility: does blood group matter?
Akgül S, Korkmaz A, Yiğit S, Yurdakök M.
Turk J Pediatr. 2013 Sep-Oct;55(5):506-9.
CD144+ endothelial microparticles as a marker of endothelial injury in neonatal ABO blood group incompatibility.
Awad HA, Tantawy AA, El-Farrash RA, Ismail EA, Youssif NM.
Blood Transfus. 2014 Apr;12(2):250-9. doi: 10.2450/2013.0101-13. Epub 2013 Nov 15.
A Comparative Analysis of the Efficacy of Blood Exchange Therapy in Neonatal Hyperbilirubinemia Induced by ABO and Rh Incompatibility.
Wu K, Chen L, Huang H, Chen D.
Int J Gen Med. 2024 Dec 9;17:5921-5927. doi: 10.2147/IJGM.S497184. eCollection 2024.
Prediction of the development of neonatal hyperbilirubinemia in ABO incompatibility.
Chen JY, Ling UP.
Zhonghua Yi Xue Za Zhi (Taipei). 1994 Jan;53(1):13-8.
Spectrum and outcome analysis of marked neonatal hyperbilirubinemia with blood group incompatibility.
Weng YH, Chiu YW.
Chang Gung Med J. 2009 Jul-Aug;32(4):400-8.
